Valentini, V.; Santi, R.; Silvestri, V.; Saieva, C.; Roviello, G.; Amorosi, A.; Compérat, E.; Ottini, L.; Nesi, G.
CD44 Methylation Levels in Androgen-Deprived Prostate Cancer: A Putative Epigenetic Modulator of Tumor Progression. Int. J. Mol. Sci. 2025, 26, 2516.
https://doi.org/10.3390/ijms26062516
AMA Style
Valentini V, Santi R, Silvestri V, Saieva C, Roviello G, Amorosi A, Compérat E, Ottini L, Nesi G.
CD44 Methylation Levels in Androgen-Deprived Prostate Cancer: A Putative Epigenetic Modulator of Tumor Progression. International Journal of Molecular Sciences. 2025; 26(6):2516.
https://doi.org/10.3390/ijms26062516
Chicago/Turabian Style
Valentini, Virginia, Raffaella Santi, Valentina Silvestri, Calogero Saieva, Giandomenico Roviello, Andrea Amorosi, Eva Compérat, Laura Ottini, and Gabriella Nesi.
2025. "CD44 Methylation Levels in Androgen-Deprived Prostate Cancer: A Putative Epigenetic Modulator of Tumor Progression" International Journal of Molecular Sciences 26, no. 6: 2516.
https://doi.org/10.3390/ijms26062516
APA Style
Valentini, V., Santi, R., Silvestri, V., Saieva, C., Roviello, G., Amorosi, A., Compérat, E., Ottini, L., & Nesi, G.
(2025). CD44 Methylation Levels in Androgen-Deprived Prostate Cancer: A Putative Epigenetic Modulator of Tumor Progression. International Journal of Molecular Sciences, 26(6), 2516.
https://doi.org/10.3390/ijms26062516
